Alternative activation of macrophages, Nature Reviews Immunology, vol.3, issue.1, pp.23-35, 2003. ,
DOI : 10.1038/nri978
URL : https://hal.archives-ouvertes.fr/hal-00474829
The molecular basis of T helper 1 and T helper 2 cell differentiation, Trends Cell Biol, vol.10, pp.542-550, 2000. ,
Can we apply the TH1-TH2 paradigm to all lymphocytes?, Nature Immunology, vol.183, issue.10, pp.899-900, 2001. ,
DOI : 10.1038/ni1001-899
Monocyte Chemotactic Protein-2 Activates CCR5 and Blocks CD4/CCR5-mediated HIV-1 Entry/Replication, Journal of Biological Chemistry, vol.273, issue.8, pp.4289-4292, 1998. ,
DOI : 10.1074/jbc.273.8.4289
Interleukin-16 inhibits human immunodeficiency virus type 1 entry and replication in macrophages and in dendritic cells, J Virol, vol.73, pp.7008-7013, 1999. ,
Interleukin-2 inhibits HIV-1 replication in human macrophages by modulating expression of CD4 and CC-chemokine receptor-5, AIDS, vol.12, issue.8, pp.59-64, 1998. ,
DOI : 10.1097/00002030-199808000-00001
Influence of interleukin-15 on CD8+ natural killer cells in human immunodeficiency virus type 1-infected chimpanzees, Journal of General Virology, vol.88, issue.2, pp.641-651, 2007. ,
DOI : 10.1099/vir.0.82154-0
Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood, pp.4272-4279, 2007. ,
Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection, J Immunol, vol.161, pp.6433-6438, 1998. ,
Elevated Levels of Circulating Interleukin-18 in Human Immunodeficiency Virus-Infected Individuals: Role of Peripheral Blood Mononuclear Cells and Implications for AIDS Pathogenesis, Journal of Virology, vol.76, issue.24, pp.12448-12456, 2002. ,
DOI : 10.1128/JVI.76.24.12448-12456.2002
Interleukin-18: A Proinflammatory Cytokine in HIV-1 Infection, Current HIV Research, vol.4, issue.4, pp.423-430, 2006. ,
DOI : 10.2174/157016206778559993
Interleukin???18 Inhibits Human Immunodeficiency Virus Type 1 Production in Peripheral Blood Mononuclear Cells, The Journal of Infectious Diseases, vol.184, issue.5, pp.560-568, 2001. ,
DOI : 10.1086/322805
SOLUBLE CD40 LIGAND INDUCES ??-CHEMOKINE PRODUCTION BY MACROPHAGES AND RESISTANCE TO HIV-1 ENTRY, Cytokine, vol.12, issue.10, pp.1489-1495, 2000. ,
DOI : 10.1006/cyto.1999.0594
The emerging role of CD40 ligand in HIV infection, J Leukoc Biol, vol.68, pp.373-382, 2000. ,
CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines, Proc Natl Acad Sci, vol.95, pp.40-5205, 1998. ,
Chemokines and T lymphocyte recruitment to lymph nodes in HIV infection, Am J Pathol, vol.148, pp.1367-1373, 1996. ,
The B-Oligomer of Pertussis Toxin Deactivates Cc Chemokine Receptor 5 and Blocks Entry of M-Tropic HIV-1 Strains, The Journal of Experimental Medicine, vol.142, issue.5, pp.597-605, 1999. ,
DOI : 10.1084/jem.164.1.280
Activationinduced resistance of human macrophages to HIV-1 infection in vitro, J Immunol, vol.162, pp.400-406, 1999. ,
Inhibition of HIV- 1 replication in primary human monocytes by the IkappaB-alphaS32/ 36A repressor of NF-kappaB, Retrovirology, vol.1, issue.1, p.45, 2004. ,
DOI : 10.1186/1742-4690-1-45
Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat., Proceedings of the National Academy of Sciences, vol.86, issue.15, pp.5974-5978, 1989. ,
DOI : 10.1073/pnas.86.15.5974
Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B., Proceedings of the National Academy of Sciences, vol.86, issue.7, pp.2336-2340, 1989. ,
DOI : 10.1073/pnas.86.7.2336
Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms, Journal of Experimental Medicine, vol.172, issue.1, pp.151-158, 1990. ,
DOI : 10.1084/jem.172.1.151
Tumor necrosis factor receptor expression and signal transduction in HIV-I-infected cells, AIDS, vol.7, issue.7, pp.911-918, 1993. ,
DOI : 10.1097/00002030-199307000-00002
Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist., Proceedings of the National Academy of Sciences, vol.91, issue.1, pp.108-112, 1994. ,
DOI : 10.1073/pnas.91.1.108
Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NFkappaB/Rel transcription factors, J Biol Chem, vol.271, pp.22479-22486, 1996. ,
NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1., Proceedings of the National Academy of Sciences, vol.90, issue.15, pp.7298-7302, 1993. ,
DOI : 10.1073/pnas.90.15.7298
Regulation of HIV-1 Transcription in Activated Monocyte Macrophages, Virology, vol.299, issue.2, pp.256-265, 2002. ,
DOI : 10.1006/viro.2001.1530
Endothelial Cells Enhance Human Immunodeficiency Virus Type 1 Replication in Macrophages through a C/EBP-Dependent Mechanism, Journal of Virology, vol.75, issue.20, pp.9703-9712, 2001. ,
DOI : 10.1128/JVI.75.20.9703-9712.2001
Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line, Science, vol.238, issue.4828, pp.800-802, 1987. ,
DOI : 10.1126/science.3313729
Cytokines alter production of HIV-1 from primary mononuclear phagocytes, Science, vol.241, issue.4873, pp.1673-1675, 1988. ,
DOI : 10.1126/science.3047875
Regulation of interleukin-18 by THP-1 monocytoid cells stimulated with HIV-1 and Nef viral protein, Eur Cytokine Netw, vol.16, pp.186-190, 2005. ,
Interleukin 18 stimulates HIV type 1 in monocytic cells, Proceedings of the National Academy of Sciences, vol.95, issue.21, pp.12550-12555, 1998. ,
DOI : 10.1073/pnas.95.21.12550
Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction, EMBO J, vol.12, pp.2663-2670, 1993. ,
Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system., Proceedings of the National Academy of Sciences, vol.89, issue.13, pp.6065-6069, 1992. ,
DOI : 10.1073/pnas.89.13.6065
The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice, Journal of Experimental Medicine, vol.176, issue.4, pp.1091-1098, 1992. ,
DOI : 10.1084/jem.176.4.1091
Bc e l l stimulatory factor-1 enhances the IgE response of lipopolysaccharideactivated B cells, J Immunol, vol.136, pp.4538-4541, 1986. ,
Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones, Journal of Experimental Medicine, vol.173, issue.3, pp.747-750, 1991. ,
DOI : 10.1084/jem.173.3.747
Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1, Journal of Experimental Medicine, vol.162, issue.5, pp.1726-1731, 1985. ,
DOI : 10.1084/jem.162.5.1726
Alternative activation of macrophages: Immune function and cellular biology, Immunobiology, vol.214, issue.7, pp.630-671, 2009. ,
DOI : 10.1016/j.imbio.2008.11.009
Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL- 10, J Immunol, vol.151, pp.6370-6381, 1993. ,
Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro, Journal of Experimental Medicine, vol.178, issue.2, pp.743-747, 1993. ,
DOI : 10.1084/jem.178.2.743
Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells, Immunology Today, vol.15, issue.1, pp.19-26, 1994. ,
DOI : 10.1016/0167-5699(94)90021-3
Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines, Trends in Immunology, vol.22, issue.6, pp.328-336, 2001. ,
DOI : 10.1016/S1471-4906(01)01941-X
IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes, J Immunol, vol.149, pp.1283-1288, 1992. ,
Role of Tyrosine Phosphorylation in Ligand-independent Sequestration of CXCR4 in Human Primary Monocytes-Macrophages, Journal of Biological Chemistry, vol.276, issue.52, pp.49236-49243, 2001. ,
DOI : 10.1074/jbc.M108523200
When is it time for reverse transcription to start and go? Retrovirology, p.24, 2009. ,
Interleukin 13 and interleukin 4 protect bronchoalveolar macrophages from productive infection with human immunodeficiency virus type 1, AIDS Res Hum Retroviruses, vol.10, pp.795-802, 1994. ,
Differential effects of interleukin-13 on cytomegalovirus and human immunodeficiency virus infection in human alveolar macrophages, pp.3443-3450, 1997. ,
IL-13 acts on macrophages to block the completion of reverse transcription, inhibit virus production, and reduce virus infectivity, J Leukoc Biol, vol.62, pp.126-132, 1997. ,
IL-4 and IL-13 have overlapping but distinct effects on HIV production in monocytes, J Leukoc Biol, vol.56, pp.340-346, 1994. ,
The state of maturation of monocytes into macrophages determines the effects of IL-4 and IL-13 on HIV replication, J Immunol, vol.158, pp.501-511, 1997. ,
Molecular mechanisms of IL-4 effect on HIV expression in promonocytic cell lines and primary human monocytes, J Leukoc Biol, vol.56, pp.335-339, 1994. ,
Effect of interleukin-1 on the augmentation of human immunodeficiency virus gene expression, Biochemical and Biophysical Research Communications, vol.165, issue.2, pp.715-721, 1989. ,
DOI : 10.1016/S0006-291X(89)80025-7
Augmentation of Human Immunodeficiency Virus Type 1 Gene Expression by Tumor Necrosis Factor ??, AIDS Research and Human Retroviruses, vol.5, issue.2, pp.131-138, 1989. ,
DOI : 10.1089/aid.1989.5.131
Cytokine regulation of human immunodeficiency virus expression, Cytokine, vol.3, issue.6, pp.531-542, 1991. ,
DOI : 10.1016/1043-4666(91)90479-W
The Role of Monocyte/Macrophages and Cytokines in the Pathogenesis of HIV Infection, Pathobiology, vol.60, issue.4, pp.246-251, 1992. ,
DOI : 10.1159/000163729
The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically?, Immunology, vol.157, issue.1, pp.1-14, 2004. ,
DOI : 10.1182/blood-2003-09-3245
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF., Journal of Clinical Investigation, vol.101, issue.4, pp.890-898, 1998. ,
DOI : 10.1172/JCI1112
Apoptotic Cells Inhibit LPS-Induced Cytokine and Chemokine Production and IFN Responses in Macrophages, Human Immunology, vol.68, issue.3, pp.156-164, 2007. ,
DOI : 10.1016/j.humimm.2006.12.008
Regulation of cytokine production during phagocytosis of apoptotic cells, Cell Research, vol.165, issue.2, pp.154-161, 2006. ,
DOI : 10.1146/annurev.immunol.19.1.683
New players in cytokine control of HIV infection, Current HIV/AIDS Reports, vol.109, issue.1, pp.27-32, 2008. ,
DOI : 10.1007/s11904-008-0005-5
Interleukin 10 Increases CCR5 Expression and HIV Infection in Human Monocytes, The Journal of Experimental Medicine, vol.83, issue.3, pp.439-444, 1998. ,
DOI : 10.1038/nm0397-338
Macrophage Colony-Stimulating Factor Antagonists Inhibit Replication of HIV-1 in Human Macrophages, The Journal of Immunology, vol.164, issue.9, pp.4955-4960, 2000. ,
DOI : 10.4049/jimmunol.164.9.4955
Interleukin-10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitro, Journal of General Virology, vol.75, issue.12, pp.3393-3400, 1994. ,
DOI : 10.1099/0022-1317-75-12-3393
Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/macrophage lineage, Blood, vol.83, pp.3591-3599, 1994. ,
IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages, J Immunol, vol.153, pp.5782-5789, 1994. ,
Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage, Journal of Experimental Medicine, vol.173, issue.3, pp.589-597, 1991. ,
DOI : 10.1084/jem.173.3.589
Natural resistance to HIV infection: The Vif???APOBEC interaction, Comptes Rendus Biologies, vol.329, issue.11, pp.871-875, 2006. ,
DOI : 10.1016/j.crvi.2006.01.012
HIV-1 Vif, APOBEC, and Intrinsic Immunity, Retrovirology, vol.5, issue.1, p.51, 2008. ,
DOI : 10.1186/1742-4690-5-51
URL : http://doi.org/10.1186/1742-4690-5-51
APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism, Med Sci Monit, vol.12, pp.92-98, 2006. ,
Turning up the volume on mutational pressure: is more of a good thing always better? ,
Human TRIM Gene Expression in Response to Interferons, PLoS ONE, vol.18, issue.3, p.4894, 2009. ,
DOI : 10.1371/journal.pone.0004894.s001
Type???I interferon-dependent and -independent expression of tripartite motif proteins in immune cells, European Journal of Immunology, vol.102, issue.3, pp.619-630, 2008. ,
DOI : 10.1002/eji.200737916
The control of viral infection by tripartite motif proteins and cyclophilin A, Retrovirology, vol.4, issue.1, p.40, 2007. ,
DOI : 10.1186/1742-4690-4-40
Restriction of retroviral replication by APOBEC3G/F and TRIM5??, Trends in Microbiology, vol.16, issue.12, pp.612-619, 2008. ,
DOI : 10.1016/j.tim.2008.08.013
APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts, PLoS Pathogens, vol.46, issue.12, p.1000231, 2008. ,
DOI : 10.1371/journal.ppat.1000231.s001
Implication of TRIMalpha and TRIMCyp in interferon-induced anti-retroviral restriction activities, Retrovirology, vol.5, issue.1, p.59, 2008. ,
DOI : 10.1186/1742-4690-5-59
Interleukin 10 Blocks HIV Replication in Macrophages by Inhibiting the Autocrine Loop of Tumor Necrosis Factor ?? and Interleukin 6 Induction of Virus, AIDS Research and Human Retroviruses, vol.10, issue.10, pp.1199-1206, 1994. ,
DOI : 10.1089/aid.1994.10.1199
IL-10 Synergizes with Multiple Cytokines in Enhancing HIV Production in Cells of Monocytic Lineage, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, vol.9, issue.5, pp.442-449, 1995. ,
DOI : 10.1097/00042560-199509050-00002
Interference of interleukin-10 with human immunodeficiency virus type 1 replication in primary monocyte-derived macrophages, J Virol, vol.68, pp.6967-6975, 1994. ,
Replication of LAV, HTLV-III, and ARV-2, Journal of Interferon Research, vol.6, issue.2, pp.143-152, 1986. ,
DOI : 10.1089/jir.1986.6.143
Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti???HIV-1 activity, The Journal of Experimental Medicine, vol.13, issue.1, pp.41-46, 2006. ,
DOI : 10.1006/meth.2001.1262
In Vitro Treatment of Human Monocytes/Macrophages with Myristoylated Recombinant Nef of Human Immunodeficiency Virus Type 1 Leads to the Activation of Mitogen-Activated Protein Kinases, I??B Kinases, and Interferon Regulatory Factor 3 and to the Release of Beta Interferon, Journal of Virology, vol.81, issue.6, pp.2777-2791, 2007. ,
DOI : 10.1128/JVI.01640-06
Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27, Blood, vol.109, issue.5, pp.1841-1849, 2007. ,
DOI : 10.1182/blood-2006-02-001578
IL-27, a novel anti-HIV cytokine, activates multiple interferon-inducible genes in macrophages, AIDS, vol.22, issue.1, pp.39-45, 2008. ,
DOI : 10.1097/QAD.0b013e3282f3356c
Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon, Blood, vol.114, issue.9, pp.1864-1874, 2009. ,
DOI : 10.1182/blood-2009-03-211540
Antiviral Activity of Innate Immune Protein ISG15, Journal of Innate Immunity, vol.1, issue.5, pp.397-404, 2009. ,
DOI : 10.1159/000226245
Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15, Proceedings of the National Academy of Sciences, vol.103, issue.5, pp.1440-1445, 2006. ,
DOI : 10.1073/pnas.0510518103
HIV accomplices and adversaries in macrophage infection, Journal of Leukocyte Biology, vol.80, issue.5, pp.973-983, 2006. ,
DOI : 10.1189/jlb.0306130
Interferon-induced exonuclease ISG20 exhibits an antiviral activity against human immunodeficiency virus type 1, Journal of General Virology, vol.86, issue.8, pp.2221-2229, 2005. ,
DOI : 10.1099/vir.0.81074-0
The Interferon Response Inhibits HIV Particle Production by Induction of TRIM22, PLoS Pathogens, vol.272, issue.2, p.1000007, 2008. ,
DOI : 10.1371/journal.ppat.1000007.s001
In vitro effect of transforming growth factor-beta on progression of HIV-1 infection in primary mononuclear phagocytes, J Immunol, vol.147, pp.1201-1207, 1991. ,
Type I Interferon Production Is Profoundly and Transiently Impaired in Primary HIV???1 Infection, The Journal of Infectious Diseases, vol.192, issue.2, pp.303-310, 2005. ,
DOI : 10.1086/430931
Is HIV infection a TNF receptor signalling-driven disease? Trends Immunol, pp.61-67, 2008. ,
Serum Levels of Tumor Necrosis Factor-?? (TNF??) and Soluble TNF Receptors in Human Immunodeficiency Virus Type 1 Infection-Correlations to Clinical, Immunologic, and Virologic Parameters, Journal of Infectious Diseases, vol.169, issue.2, pp.420-424, 1994. ,
DOI : 10.1093/infdis/169.2.420
Localization of HIV-1 Vpr to the nuclear envelope: Impact on Vpr functions and virus replication in macrophages, Retrovirology, vol.4, issue.1, p.84, 2007. ,
DOI : 10.1186/1742-4690-4-84
Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage, Retrovirology, vol.6, issue.1, p.118, 2009. ,
DOI : 10.1186/1742-4690-6-118
Differential expression of IFN-?? and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients, Proceedings of the National Academy of Sciences, vol.103, issue.18, pp.7000-7005, 2006. ,
DOI : 10.1073/pnas.0600363103
Impact of HIV on Cell Survival and Antiviral Activity of Plasmacytoid Dendritic Cells, PLoS ONE, vol.84, issue.5, p.458, 2007. ,
DOI : 10.1371/journal.pone.0000458.s001
THE IL-4 RECEPTOR: Signaling Mechanisms and Biologic Functions, Annual Review of Immunology, vol.17, issue.1, pp.701-738, 1999. ,
DOI : 10.1146/annurev.immunol.17.1.701
IL-13 Acutely Augments HIV-Specific and Recall Responses from HIV-1-Infected Subjects In Vitro by Modulating Monocytes, The Journal of Immunology, vol.175, issue.8, pp.5532-5540, 2005. ,
DOI : 10.4049/jimmunol.175.8.5532
Macrophage Polarization in Bacterial Infections, The Journal of Immunology, vol.181, issue.6, pp.3733-3739, 2008. ,
DOI : 10.4049/jimmunol.181.6.3733
Transcriptome Analysis of Murine Macrophages in Response to Infection with Streptococcus pyogenes Reveals an Unusual Activation Program, Infection and Immunity, vol.75, issue.8, pp.4148-4157, 2007. ,
DOI : 10.1128/IAI.00181-07
Macrophages and T-cell apoptosis in HIV infection: a leading role for accessory cells?, Trends in Immunology, vol.22, issue.5, pp.256-260, 2001. ,
DOI : 10.1016/S1471-4906(01)01898-1
Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion, Blood, vol.115, issue.2, pp.353-62, 2009. ,
DOI : 10.1182/blood-2009-08-236711
URL : https://hal.archives-ouvertes.fr/hal-00474829
Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4, Nature, vol.395, pp.189-194, 1998. ,
Enhanced Apoptotic Cell Clearance Capacity and B Cell Survival Factor Production by IL-10-Activated Macrophages: Implications for Burkitt's Lymphoma, The Journal of Immunology, vol.174, issue.5, pp.3015-3023, 2005. ,
DOI : 10.4049/jimmunol.174.5.3015
Lipopolysaccharide Induces Rapid Production of IL-10 by Monocytes in the Presence of Apoptotic Neutrophils, The Journal of Immunology, vol.168, issue.4, pp.1968-1977, 2002. ,
DOI : 10.4049/jimmunol.168.4.1968
A TH1???TH2 switch is a critical step in the etiology of HIV infection, Immunology Today, vol.14, issue.3, pp.107-111, 1993. ,
DOI : 10.1016/0167-5699(93)90208-3
Extended IL10 haplotypes and their association with HIV progression to AIDS, Genes and Immunity, vol.32, issue.4, pp.309-322, 2009. ,
DOI : 10.1002/gepi.20037
Genomic analysis of Th1???Th2 cytokine genes in an AIDS cohort: identification of IL4 and IL10 haplotypes associated with the disease progression, Genes and Immunity, vol.4, issue.6, pp.441-449, 2003. ,
DOI : 10.1038/sj.gene.6363983
IL-10 Enhances MD-2 and CD14 Expression in Monocytes and the Proteins Are Increased and Correlated in HIV-Infected Patients, The Journal of Immunology, vol.182, issue.1, pp.588-595, 2009. ,
DOI : 10.4049/jimmunol.182.1.588
Nef Protein of Human Immunodeficiency Virus and Lipopolysaccharide Induce Expression of CD14 on Human Monocytes through Differential Utilization of Interleukin-10, Clinical and Vaccine Immunology, vol.9, issue.6, pp.1212-1221, 2002. ,
DOI : 10.1128/CDLI.9.6.1212-1221.2002
Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor ?? production, AIDS, vol.21, issue.13, pp.1763-1770, 2007. ,
DOI : 10.1097/QAD.0b013e3282ca83fa
IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection, Proceedings of the National Academy of Sciences, vol.105, issue.51, pp.20428-20433, 2008. ,
DOI : 10.1073/pnas.0811139106
HIV-1 Tat Suppresses gp120-Specific T Cell Response in IL-10-Dependent Manner, The Journal of Immunology, vol.180, issue.1, pp.79-88, 2008. ,
DOI : 10.4049/jimmunol.180.1.79
Monocyte/macrophage-derived CC chemokines and their modulation by HIV-1 and cytokines: A complex network of interactions influencing viral replication and AIDS pathogenesis, Journal of Leukocyte Biology, vol.74, issue.5, pp.719-725, 2003. ,
DOI : 10.1189/jlb.0403175
IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression, The FASEB Journal, vol.20, issue.12, pp.2112-2114, 2006. ,
DOI : 10.1096/fj.06-6084fje
Interleukin-10 inhibits HIV-1 LTR-directed gene expression in human macrophages through the induction of cyclin T1 proteolysis, Virology, vol.352, issue.2, pp.485-492, 2006. ,
DOI : 10.1016/j.virol.2006.05.013
T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract, The Journal of Experimental Medicine, vol.72, issue.6, pp.749-759, 2004. ,
DOI : 10.4049/jimmunol.167.12.6711
Severe CD4+ T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy, Journal of Virology, vol.77, issue.21, pp.11708-11717, 2003. ,
DOI : 10.1128/JVI.77.21.11708-11717.2003
Viral Suppression and Immune Restoration in the Gastrointestinal Mucosa of Human Immunodeficiency Virus Type 1-Infected Patients Initiating Therapy during Primary or Chronic Infection, Journal of Virology, vol.80, issue.16, pp.8236-8247, 2006. ,
DOI : 10.1128/JVI.00120-06
Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells, Nature, vol.139, pp.1148-1152, 2005. ,
DOI : 10.1038/nm0703-847
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection, Nature, vol.82, issue.7037, pp.1093-1097, 2005. ,
DOI : 10.1084/jem.164.1.280
T Lymphocytes from Effector Sites in the Gastrointestinal Tract, The Journal of Experimental Medicine, vol.73, issue.6, pp.761-770, 2004. ,
DOI : 10.1038/nm833
Mechanisms of Gastrointestinal CD4+ T-Cell Depletion during Acute and Early Human Immunodeficiency Virus Type 1 Infection, Journal of Virology, vol.81, issue.2, pp.599-612, 2007. ,
DOI : 10.1128/JVI.01739-06
Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe CD4(+) T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes, J Virol, vol.72, pp.6646-6656, 1998. ,
Gastrointestinal Tract as a Major Site of CD4+ T Cell Depletion and Viral Replication in SIV Infection, Science, vol.280, issue.5362, pp.427-431, 1998. ,
DOI : 10.1126/science.280.5362.427
Intestinal macrophages display reduced permissiveness to human immunodeficiency virus 1 and decreased surface CCR5, Gastroenterology, vol.116, issue.5, pp.1043-1053, 1999. ,
DOI : 10.1016/S0016-5085(99)70007-7
Lamina Propria Lymphocytes, Not Macrophages, Express CCR5 and CXCR4 and Are the Likely Target Cell for Human Immunodeficiency Virus Type 1 in the Intestinal Mucosa, The Journal of Infectious Diseases, vol.182, issue.3, pp.785-791, 2000. ,
DOI : 10.1086/315790
Macrophage Tropism of Human Immunodeficiency Virus Type 1 Isolates from Brain and Lymphoid Tissues Predicts Neurotropism Independent of Coreceptor Specificity, Journal of Virology, vol.75, issue.21, pp.10073-10089, 2001. ,
DOI : 10.1128/JVI.75.21.10073-10089.2001
Intestinal Macrophages Lack CD14 and CD89 and Consequently Are Down-Regulated for LPS- and IgA-Mediated Activities, The Journal of Immunology, vol.167, issue.5, pp.2651-2656, 2001. ,
DOI : 10.4049/jimmunol.167.5.2651
Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity, Journal of Clinical Investigation, vol.115, issue.1, pp.66-75, 2005. ,
DOI : 10.1172/JCI200519229
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC539188/pdf
Macrophages Expressing Triggering Receptor Expressed on Myeloid Cells-1 Are Underrepresented in the Human Intestine, The Journal of Immunology, vol.174, issue.1, pp.517-524, 2005. ,
DOI : 10.4049/jimmunol.174.1.517
TREM-1???expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases, Journal of Clinical Investigation, vol.117, issue.10, pp.3097-3106, 2007. ,
DOI : 10.1172/JCI30602DS1
Differential distribution of B7.1 (CD80) and B7.2 (CD86) costimulatory molecules on mucosal macrophage subsets in human inflammatory bowel disease (IBD), Clinical and Experimental Immunology, vol.110, issue.1, pp.104-113, 1997. ,
DOI : 10.1111/j.1365-2249.1997.507-ce1404.x
Macrophage HIV-1 infection and the gastrointestinal tract reservoir, Journal of Leukocyte Biology, vol.74, issue.5, pp.642-649, 2003. ,
DOI : 10.1189/jlb.0503219
Intestinal macrophages: unique effector cells of the innate immune system, Immunological Reviews, vol.112, issue.1, pp.149-159, 2005. ,
DOI : 10.1126/science.1103685
Macrophages in Vaginal but Not Intestinal Mucosa Are Monocyte-Like and Permissive to Human Immunodeficiency Virus Type 1 Infection, Journal of Virology, vol.83, issue.7, pp.3258-3267, 2009. ,
DOI : 10.1128/JVI.01796-08
Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: Lessons from human and nonhuman primate studies, Journal of Neurovirology, vol.14, issue.4, pp.318-326, 2008. ,
DOI : 10.1080/13550280802132857
Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy, Science, vol.233, issue.4768, pp.1089-1093, 1986. ,
DOI : 10.1126/science.3016903
Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis, Neurology, vol.59, issue.10, pp.1563-1567, 2002. ,
DOI : 10.1212/01.WNL.0000034175.11956.79
AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines, Mol Med, vol.2, pp.358-366, 1996. ,
Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues, Neurology, vol.44, issue.3, Part 1, pp.474-481, 1994. ,
DOI : 10.1212/WNL.44.3_Part_1.474
HIV-1 associated dementia: symptoms and causes, Retrovirology, vol.3, issue.1, p.28, 2006. ,
DOI : 10.1186/1742-4690-3-28
Early viral brain invasion in iatrogenic human immunodeficiency virus infection, Neurology, vol.42, issue.9, pp.1736-1739, 1992. ,
DOI : 10.1212/WNL.42.9.1736
See no evil, hear no evil, do no evil: the lessons of immune privilege, Nature Immunology, vol.420, issue.4, pp.354-359, 2006. ,
DOI : 10.1038/ni1328
TRANSFORMING GROWTH FACTOR-?? REGULATION OF IMMUNE RESPONSES, Annual Review of Immunology, vol.24, issue.1, pp.99-146, 2006. ,
DOI : 10.1146/annurev.immunol.24.021605.090737
Transforming growth factorbeta 1-mediated neuroprotection against excitotoxic injury in vivo, J Cereb Blood Flow Metab, vol.23, pp.1174-1182, 2003. ,
Immune privilege and HIV-1 persistence in the CNS, Immunological Reviews, vol.177, issue.1, pp.180-194, 2006. ,
DOI : 10.1189/jlb.0503205
Specific suppression of major histocompatibility complex class I and class II genes in astrocytes by brain-enriched gangliosides, Journal of Experimental Medicine, vol.178, issue.4, pp.1357-1363, 1993. ,
DOI : 10.1084/jem.178.4.1357
Expression of major histocompatibility complex and HIV antigens within the brains of AIDS patients, AIDS, vol.5, issue.5, pp.535-541, 1991. ,
DOI : 10.1097/00002030-199105000-00009
Investigation on the expression of major histocompatibility complex class II and cytokines and detection of HIV-1 DNA within brains of asymptomatic and symptomatic HIV-1-positive patients, Acta Neuropathologica, vol.91, issue.5, pp.494-503, 1996. ,
DOI : 10.1007/s004010050457
Microglial and Astrocyte Chemokines Regulate Monocyte Migration through the Blood-Brain Barrier in Human Immunodeficiency Virus-1 Encephalitis, The American Journal of Pathology, vol.155, issue.5, pp.1599-1611, 1999. ,
DOI : 10.1016/S0002-9440(10)65476-4
The brain as an immune privileged site: dendritic cells of the central nervous system inhibit T cell activation, European Journal of Immunology, vol.33, issue.11, pp.2998-3006, 2003. ,
DOI : 10.1002/eji.200323611
Immunization with dendritic cells can break immunological ignorance toward a persisting virus in the central nervous system and induce partial protection against intracerebral viral challenge, Journal of General Virology, vol.85, issue.8, pp.2379-2387, 2004. ,
DOI : 10.1099/vir.0.80115-0
Distribution and Immunophenotype of DC-SIGN-Expressing Cells in SIV-Infected and Uninfected Macaques, AIDS Research and Human Retroviruses, vol.18, issue.14, pp.1021-1029, 2002. ,
DOI : 10.1089/08892220260235380
Early Brain Changes in HIV Infection, Journal of Neuropathology and Experimental Neurology, vol.51, issue.2, pp.177-185, 1992. ,
DOI : 10.1097/00005072-199203000-00007
Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis, Blood, vol.106, issue.7, pp.2382-2390, 2005. ,
DOI : 10.1182/blood-2005-04-1403
An immune control model for viral replication in the CNS during presymptomatic HIV infection, Brain, vol.129, issue.2, pp.503-516, 2006. ,
DOI : 10.1093/brain/awh695
Neuropathology of Early HIV-1 Infection, Brain Pathology, vol.19, issue.1, pp.1-15, 1996. ,
DOI : 10.1002/ana.410200316
Central nervous system lesions in the early stages of HIV infection], Arch Anat Cytol Pathol, vol.45, pp.106-117, 1997. ,
HIV-associated cognitive impairment before and after the advent of combination therapy, Journal of Neurovirology, vol.8, issue.2, pp.136-142, 2002. ,
DOI : 10.1080/13550280290049615
Proteomic Modeling for HIV-1 Infected Microglia-Astrocyte Crosstalk, PLoS ONE, vol.180, issue.6, p.2507, 2008. ,
DOI : 10.1371/journal.pone.0002507.t002
URL : http://doi.org/10.1371/journal.pone.0002507
Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry, Annals of Neurology, vol.38, issue.6, pp.705-711, 1996. ,
DOI : 10.1002/ana.410390606
Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120, Virology, vol.312, issue.1, pp.60-73, 2003. ,
DOI : 10.1016/S0042-6822(03)00181-8
Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia, J Biol Chem, vol.271, pp.15303-15306, 1996. ,
Astrocyte activation and dysfunction and neuron death by HIV-1 Tat expression in astrocytes, Molecular and Cellular Neuroscience, vol.27, issue.3, pp.296-305, 2004. ,
DOI : 10.1016/j.mcn.2004.07.003
Microglia in human immunodeficiency virus-associated neurodegeneration, Glia, vol.22, issue.2, pp.240-251, 2002. ,
DOI : 10.1002/glia.10155
Neurological complications of HIV infection, The Lancet Neurology, vol.4, issue.9, pp.543-555, 2005. ,
DOI : 10.1016/S1474-4422(05)70165-4
Cytokine expression in the brain during the acquired immunodeficiency syndrome, Annals of Neurology, vol.2, issue.4, pp.349-360, 1992. ,
DOI : 10.1002/ana.410310402
Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry, Journal of Neuroimmunology, vol.74, issue.1-2, pp.1-8, 1997. ,
DOI : 10.1016/S0165-5728(96)00160-9
Expression of proinflammatory cytokines and its relationship with virus infection in the brain of macaques inoculated with macrophage-tropic simian immunodeficiency virus, Neuropathology, vol.6, issue.1, pp.13-19, 2009. ,
DOI : 10.1111/j.1440-1789.2008.00929.x
M1 and M2a Polarization of Human Monocyte-Derived Macrophages Inhibits HIV-1 Replication by Distinct Mechanisms, The Journal of Immunology, vol.182, issue.10, pp.6237-6246, 2009. ,
DOI : 10.4049/jimmunol.0803447
Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?, Journal of Internal Medicine, vol.371, issue.1, pp.78-96, 2009. ,
DOI : 10.1111/j.1365-2796.2008.02043.x